2006
DOI: 10.1016/j.bbadis.2006.07.001
|View full text |Cite
|
Sign up to set email alerts
|

Diagnosis of the neuronal ceroid lipofuscinoses: An update

Abstract: For the majority of families affected by one of the neuronal ceroid lipofuscinoses (NCLs), a biochemical and/or genetic diagnosis can be achieved. In an individual case this information not only increases understanding of the condition but also may influence treatment choices and options. The presenting clinical features prompt initial investigation and also guide clinical care. The clinical labels "infantile NCL", "late infantile NCL" and "juvenile NCL", therefore remain useful in practice. In unusual or atyp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
114
1

Year Published

2009
2009
2021
2021

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 106 publications
(117 citation statements)
references
References 52 publications
2
114
1
Order By: Relevance
“…6 The infantile onset form of the disease (INCL) is one of the more severe forms, with symptoms such as blindness, ataxia, and mental decline beginning to appear by 6-12 mo of age. [7][8][9] Mutations in the soluble lysosomal enzyme Ppt1 are the underlying molecular cause of the disease, but it is still unclear why the loss of this ubiquitously expressed protein produces a very specific neurodegenerative phenotype. 4 The disease phenotype provides further support that efficient Infantile-onset neuronal ceroid lipofuscinosis (INCL) is a severe pediatric neurodegenerative disorder produced by mutations in the gene encoding palmitoyl-protein thioesterase 1 (Ppt1).…”
Section: Introductionmentioning
confidence: 99%
“…6 The infantile onset form of the disease (INCL) is one of the more severe forms, with symptoms such as blindness, ataxia, and mental decline beginning to appear by 6-12 mo of age. [7][8][9] Mutations in the soluble lysosomal enzyme Ppt1 are the underlying molecular cause of the disease, but it is still unclear why the loss of this ubiquitously expressed protein produces a very specific neurodegenerative phenotype. 4 The disease phenotype provides further support that efficient Infantile-onset neuronal ceroid lipofuscinosis (INCL) is a severe pediatric neurodegenerative disorder produced by mutations in the gene encoding palmitoyl-protein thioesterase 1 (Ppt1).…”
Section: Introductionmentioning
confidence: 99%
“…The neuronal ceroid lipofuscinoses (NCL) are a heterogeneous group of pediatric neurodegenerative disorders (Mole et al, 2005;Haltia, 2006;Williams et al, 2006) sharing the clinical symptoms of macular-cerebral OFFICIAL JOURNAL www.hgvs.org…”
Section: Introductionmentioning
confidence: 99%
“…Histochemically, lysosomal acid phosphatase activity is associated with the storage material. Immunohistochemcially, a few extremely hydrophobic proteins are detected in the lipopigment storage material; these include subunit c of the mitochondrial ATP synthase and sphingolipid activator proteins (SAPs or saposins) A and D [39][40][41][42][43][44][45].…”
Section: Ultrastructural Patternsmentioning
confidence: 99%
“…By late second to early third decades, the patients are nonambulatory. This is followed by death, usually within a year [39,40,[79][80][81][82][83][84][85][86][87][88][89]. At autopsy, the brain is small with a moderate to severe decrease in weight and grey and white matter atrophy.…”
Section: Rakheja and Mj Bennett / Neuronal Ceroid-lipofuscinosesmentioning
confidence: 99%
See 1 more Smart Citation